The issuance of convertible senior notes by Cardlytics could have a neutral to slightly positive impact on its stock price in the short term. While the influx of capital could be seen as a positive sign of growth or expansion, the increase in debt and the dilution potential from the conversion of these notes into equity could temper investor enthusiasm. The interest rate of 4.25% is relatively moderate, indicating a balanced approach to financing.